Cite
Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients
MLA
Yoshimura, Akihiro, et al. Retrospective Analysis of Docetaxel in Combination with Ramucirumab for Previously Treated Non-Small Cell Lung Cancer Patients. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1375193932&authtype=sso&custid=ns315887.
APA
Yoshimura, A., Yamada, T., Okuma, Y., Kitadai, R., Takeda, T., Kanematsu, T., Goto, H., Yoneda, H., Harada, T., Kubota, Y., Yamada, T., Date, K., Shiotsu, S., Nagata, K., Chihara, Y., Kaneko, Y., Uchino, J., Nishioka, Y., & Takayama, K. (2019). Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients.
Chicago
Yoshimura, Akihiro, Tadaaki Yamada, Yusuke Okuma, Rui Kitadai, Takayuki Takeda, Takanori Kanematsu, Hisatsugu Goto, et al. 2019. “Retrospective Analysis of Docetaxel in Combination with Ramucirumab for Previously Treated Non-Small Cell Lung Cancer Patients.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1375193932&authtype=sso&custid=ns315887.